Diagnostic Products Corp. to launch CAM 17.1 pancreatic cancer assay in Europe this month.
This article was originally published in The Gray Sheet
Executive Summary
DIAGNOSTIC PRODUCTS CAM 17.1 PANCREATIC CANCER ASSAY EUROPEAN LAUNCH slated for April, the Los Angeles, California immunodiagnostic firm says. The assay will allow physicians to "quickly and economically assess the patient for pancreatic cancer, allowing immediate follow up when the test result is positive and reducing the need for more expensive medical imaging," DPC says in a March 21 release.